Skip to main content
. 2018 Apr 5;7(8):e008773. doi: 10.1161/JAHA.118.008773

Figure 6.

Figure 6

Survival curves for nongastrointestinal (non‐GI) bleeding comparing the 3 anticoagulants (warfarin [WARF], dabigatran [DABI], and rivaroxaban [RIVA]) in patients without valvular heart disease with newly diagnosed atrial fibrillation.